PL3348307T3 - Kompozycja zawierająca karnitynę, cholan sodu, octan sodu i ewentualnie srebro do zastosowania w leczeniu łuszczycy - Google Patents

Kompozycja zawierająca karnitynę, cholan sodu, octan sodu i ewentualnie srebro do zastosowania w leczeniu łuszczycy

Info

Publication number
PL3348307T3
PL3348307T3 PL18151315T PL18151315T PL3348307T3 PL 3348307 T3 PL3348307 T3 PL 3348307T3 PL 18151315 T PL18151315 T PL 18151315T PL 18151315 T PL18151315 T PL 18151315T PL 3348307 T3 PL3348307 T3 PL 3348307T3
Authority
PL
Poland
Prior art keywords
carnitine
psoriasis
treatment
composition
sodium
Prior art date
Application number
PL18151315T
Other languages
English (en)
Inventor
Enrico Magni
Original Assignee
Gk Pharma Consultants Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gk Pharma Consultants Sa filed Critical Gk Pharma Consultants Sa
Publication of PL3348307T3 publication Critical patent/PL3348307T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL18151315T 2017-01-16 2018-01-12 Kompozycja zawierająca karnitynę, cholan sodu, octan sodu i ewentualnie srebro do zastosowania w leczeniu łuszczycy PL3348307T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102017000004019A IT201700004019A1 (it) 2017-01-16 2017-01-16 Composizione comprendente carnitina, colato di sodio, acetato di sodio ed eventualmente argento per uso nel trattamento di psoriasi, vitiligine e rosacea
EP18151315.1A EP3348307B1 (en) 2017-01-16 2018-01-12 Composition comprising carnitine, sodium cholate, sodium acetate and optionally silver for use in the treatment of psoriasis

Publications (1)

Publication Number Publication Date
PL3348307T3 true PL3348307T3 (pl) 2022-05-16

Family

ID=58995037

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18151315T PL3348307T3 (pl) 2017-01-16 2018-01-12 Kompozycja zawierająca karnitynę, cholan sodu, octan sodu i ewentualnie srebro do zastosowania w leczeniu łuszczycy

Country Status (8)

Country Link
US (1) US20180200297A1 (pl)
EP (1) EP3348307B1 (pl)
DK (1) DK3348307T3 (pl)
ES (1) ES2910949T3 (pl)
IT (1) IT201700004019A1 (pl)
MA (1) MA44742A (pl)
PL (1) PL3348307T3 (pl)
PT (1) PT3348307T (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7165534B2 (ja) * 2018-08-09 2022-11-04 花王株式会社 白斑の予防又は改善剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522694A1 (de) * 1995-06-22 1997-01-02 Vinas Jose Maria De Moragas Teerhaltige Zusammensetzung und diese enthaltende pharmazeutische und kosmetische Zubereitung
DE10133200A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Carnitin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
FR2850276B1 (fr) 2003-01-23 2005-03-04 Louis Gerald Alcindor Composition anti-exsudante et/ou anti-desquamante et/ou anti-exfoliante
DE102006021198B4 (de) * 2006-05-06 2008-01-17 Stüttgen, Dieter, Dipl.-Chem. Dermale Anwendung konzentrierter wässriger Lösungen aus Natriumchlorid oder anderen nicht giftigen anorganischen oder organischen Natriumsalzen als Mittel gegen die Hautkrankheit Vitiligo
HUP1300647A2 (hu) * 2013-11-12 2015-05-28 Druggability Technologies Ip Holdco Jersey Ltd Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik
ES2600488T3 (es) * 2014-05-23 2017-02-09 Ares Trading S.A. Composición farmacéutica líquida

Also Published As

Publication number Publication date
EP3348307A1 (en) 2018-07-18
US20180200297A1 (en) 2018-07-19
PT3348307T (pt) 2022-04-04
MA44742A (fr) 2019-02-27
EP3348307B1 (en) 2022-03-02
IT201700004019A1 (it) 2018-07-16
ES2910949T3 (es) 2022-05-17
DK3348307T3 (da) 2022-03-14

Similar Documents

Publication Publication Date Title
IL256085B (en) A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment
GB2548873B (en) Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
EP3325473A4 (en) Compounds and uses thereof in the treatment of cancer and other medical disorders
EP3250609A4 (en) Il13ra alpha 2 binding agents and use thereof in cancer treatment
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
EP3380086A4 (en) USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER
EP3332012A4 (en) GLP-1 AND USE THEREOF IN COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES
BR112016027043A2 (pt) Combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
GB201511382D0 (en) Novel compounds and their use in therapy
EP3873613A4 (en) 5-HALOURACIL MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER
EP3267989A4 (en) Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
EP3266865A4 (en) Cell therapeutic agent for cancer treatment and combination therapy with same
DK3383872T3 (da) 1,3,4-thiadiazolforbindelser og anvendelse deraf i cancerbehandling
GB201820659D0 (en) Novel compostions and their use in therapy
EP3406258A4 (en) MEDICAMENT FOR USE IN THE TREATMENT OF GOUTTE
EP3337784A4 (en) USE OF UREIDOMUSTIN (BO-1055) IN THE TREATMENT OF CANCER
IL280389A (en) Bile acid receptor modulators conjugated to G.1 protein and methods of using them
EP3344233A4 (en) TRANSDERMAL FORMULATIONS FOR THE DELIVERY OF DOXYCLYCLIN AND THEIR USE IN THE TREATMENT OF DOXYCLYCLIN-RELATED ILLNESSES AND SUFFERING
EP3380468B8 (en) Bis-pyridazine compounds and their use in treating cancer
IL269121A (en) Usl-311 for use in the treatment of cancer
HUE045185T2 (hu) Új terápiás vegyület és terápiában történõ alkalmazása
PL3348307T3 (pl) Kompozycja zawierająca karnitynę, cholan sodu, octan sodu i ewentualnie srebro do zastosowania w leczeniu łuszczycy
EP3208262A4 (en) Compounds derived from 3-alkylamino-1h-indole acrylate, and the use thereof in the treatment of neurodegenerative diseases
GB201514015D0 (en) Novel pyridazinones and their use in the treatment of cancer
PL3585422T3 (pl) Kompozycja antyseptyczna zawierająca unitiol i dimetylosulfotlenek, zastosowanie kompozycji oraz sposób leczenia ran z jej zastosowaniem